Corteva's Viatude fungicide offers preventive and curative action on white mold to reduce disease infection.

Corteva's Viatude fungicide offers preventive and curative action on white mold to reduce disease infection.

Evogene Ltd. (NASDAQ: EVGN), a leading computational biology company, has announced its financial results for the first quarter of 2025. The company reported total revenues of approximately $2.4 million, a decrease from $4.2 million in the first quarter of 2024. The primary driver of revenue in the first quarter of 2025 was an increase in seed sales by Casterra.

The decrease in revenues is attributed to a change in delivery schedules for Casterra's seeds from 2024 to 2025. Evogene implemented an expense reduction plan during the fourth quarter of 2024 and the beginning of 2025, which is expected to continue.

The company's financial results for the first quarter of 2025 will be discussed in a conference call scheduled for May 21, 2025, at 9:00 AM Eastern Time. The conference call will be available online on the company's website.

For more details, please refer to the official press release [1].

References:
1. https://quantisnow.com/company/EVGN